PROGRESS OF DEVELOPMENT
Disclosuring of information after Phase 1
| Drug | Indication | Status (Region) |
|---|---|---|
| Difluprednate | inflammation associated with ocular surgery, Uveitis | Approved (Russia) |
| SJP-0132 | Dry eye | P3（Japan） |
| SJP-0135 | Glaucoma | P3（Japan） |
| SJP-0008 | Central Retinal Artery Occlusion (CRAO) | P3（Japan） |
| SJP-0170 | Glaucoma | P3（Japan） |
| Pranoprofen | inflammation | Application under review (Vietnam) |